Video-on-Demand Library

Play

PSI EIWG Webinar: Estimands in Oncology - How and Why

02 June 2021

You will be guided through a case study (CheckMate 037) and interactively deepen the knowledge to gain hands-on experience in developing estimands. You will be introduced to the background and disease context of the case study, the concept of an estimand, and important clinical events (increased dropout rate and crossover therapy) that occurred in the trial and affected interpretation of the results. Using non-technical language and clear graphical presentation of the concepts, you will experience how the estimand framework provides a common language to describe the diversity of patient journeys and why it is important to address the right question in clinical trials. Target audience (no prior knowledge in oncology or of estimands required): Clinicians, Investigators, Regulatory Experts, Medical Writers, Ethics Committees, Statisticians.

The targeted learning outcomes are as follows: - Recognize the benefits of following the estimand framework (ICH E9 (R1) addendum) in the context of a clinical trial, in order to: - have a common language to describe the diversity of patient journeys - address the right question in clinical trials - Be able to construct an estimand, including identification of relevant intercurrent events and application of relevant strategies to address them - Gain insights from a cross-industry international working group on estimands in oncology Presented by members of the Estimands in Oncology special interest group www.oncoestimand.org 

Contents
05:33 Learning Outcomes
06:30 Introduction to the case study
15:55 Intermezzo - Comic
17:20 Estimands in Oncology - How and Why
     17:20 ICH E9 (R1) Estimand Framework
     21:40 Five Components of an Estimand
     25:15 Five Strategies for Intercurrent Events
42:43 Revisiting the case study
     45:00 Estimand for the primary analysis
     47:21 Estimand for the post-hoc analysis
49:20 Interactive quiz with Q&A
1:18:40 Concluding Remarks
1:20:30 General Q&A
 

Part of Collection(s)

Topic(s)

Upcoming Events

PSI VisSIG Wonderful Wednesday Webinar Series

This is a good opportunity to develop your knowledge by thinking through a practical example, practicing how to apply graphics principles, and developing your coding skills.

PSI VIS SIG Webinar: Collaborative & Exploratory Data Analysis

In this talk, you will learn how to quickly explore your data in the web browser and how to create, collaborate and share interactive visualisations with others.

PSI Pre-Clinical SIG Webinar: Assay Qualification by Linear Mixed Model: Confidence, Prediction & Tolerance Intervals

Dr Francq will discuss the need for analytical methods to deliver unbiased and precise results and talk in detail on confidence, prediction and tolerance intervals work in linear mixed models and the interpretation of statistical results. This will be followed by Q&A.

PSI Training Course: An Interactive Introduction to Agile Ways of Working

During this session you will explore how we best execute change within our roles, build your practical understanding of agile tools and techniques, and inspire you to experiment with the new ways of working to deliver your goals.

PSI EIWG Webinar: Impact of estimands

To understand how the estimand framework changed the development of clinical trials.

PSI Training Course: Hybrid Frequentist / Bayesian Power and Bayesian Power in Planning Clinical Trials

Aimed at Statisticians working on the design of Clinical Trials, participants will learn how to use Expected Power, Average Power, Predicted Power, Probability of Success and Assurance, and Bayesian Power when planning clinical trials.

Latest Jobs

Apprentice Biostatistician

The Apprentice Biostatistician splits their time between working for Parexel and performing studies with a university to obtain a MSc in Statistics over a period of three years.

Biostatistician / Statistical Programmer

We are actively looking to expand our team in Wokingham with a permanent position for a Biostatistician / Statistical Programmer.

Principal Statistician combining biomarker analysis with clinical data

We are looking for a Principal Statistician to be part of exciting work combing clinical trial data and biomarker data to support the future development of molecules within the therapeutic areas of obesity and NASH.

Statistical experts for cardio-renal outcome trials

Biostatistics GLP-1 & CV 1 is seeking statisticians at Specialist and Principal level to be part of the biostatistics team responsible for Novo Nordisk’s large cardiovascular outcomes trials.

Statistical experts for drug development

The position will be made to match the seniority of the candidate and for the right candidate we offer the opportunity to work mostly homebased from European locations.